• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Bruce Feinberg Explains Why He Attends AJMC's Patient-Centered Oncology Care

Video

Bruce Feinberg, DO, vice president and chief medical office at Cardinal Health Specialty Solutions, explains why he attends the sessions at Patient-Centered Oncology Care.

vice president and chief medical officer, Cardinal Health Specialty Solutions

For the past 3 years, Bruce Feinberg, DO, , has not just presented at the Patient-Centered Oncology Care meeting, but he's stayed to attend the sessions as well because of the uniqueness of the program.

"It is a fairly unique aggregation of stakeholders," he said. "It's rare to get providers and payers and pharmaceutical companies and patient advocacy in a room at the same time."

View the full agenda, learn more, and register now: www.ajmc.com/meetings/pcoc15

Related Videos
Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center
Merrill H. Stewart, MD
Dr Carrie Kitko
Jeffrey Fitzgerald, JD
Dr Carrie Kitko
Merrill H. Stewart, MD
Related Content
The investigators found that patients with SCLC and cachexia were more likely to have problems with treatment. | Image credit: appledesign - stock.adobe.com

Cachexia Worsens Prognosis in Older Patients With Advanced SCLC

July 9th 2025
Article

Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than patients with cachexia.

Read More

Managed Care Cast

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

July 1st 2025
Podcast

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

Listen

Constantine Farmakidis, MD | Image Credit: University of Kansas Medical Center

A Closer Look at Nipocalimab’s Impact on Myasthenia Gravis Care: Constantine Farmakidis, MD

July 3rd 2025
Article

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved patient outcomes across diverse populations.

Read More

Managed Care Cast

Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care

June 24th 2025
Podcast

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.

Listen

While elevated NLR previously served as a marker of aggressive disease and poor prognosis in SCLC, its prognostic relevance appears to diminish in the context of immunotherapy-based treatment regimens. | Image credit: Crystal light - stock.adobe.com

Challenging the Prognostic Role of NLR in SCLC in the Era of Immunotherapy

June 27th 2025
Article

Elevated NLR may no longer predict poor survival outcomes in patients with small cell lung cancer (SCLC) receiving immunotherapy, according to new research.

Read More

Hamlet Gasoyan, PhD

Improve Antiobesity Medication Adherence to Improve Results: Hamlet Gasoyan, PhD

June 26th 2025
Article

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.